Tharimmune Executive Chairman Buys $500K in Stock, Increases Holdings
Gravitas Capital LP, a significant insider at Tharimmune (THAR), has reported a substantial purchase of company shares.
Rhea-AI Filing Summary
Gravitas Capital LP, a significant insider at Tharimmune (THAR), has reported a substantial purchase of company shares. On June 20, 2025, the entity acquired 337,838 shares of Common Stock at a price of $1.48 per share, representing a total investment of approximately $500,000.
Following this transaction, Gravitas Capital LP now owns 732,424 shares directly. The reporting person holds multiple positions within the company, serving as:
- Executive Chairman
- Director
- 10% Owner
This insider purchase by a high-ranking executive and major shareholder could signal confidence in the company's future prospects. The transaction was reported within the required filing deadline, with the Form 4 being signed by Vincent LoPriore on June 23, 2025.
Positive
- Executive Chairman and 10% owner Gravitas Capital LP purchased 337,838 shares at $1.48 per share for approximately $500,000, demonstrating significant insider confidence through open market purchase
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 337,838 | $1.48 | $500K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Gravitas Capital LP's total position in THAR stock after their June 2025 purchase?
What positions does Gravitas Capital LP hold at THAR?
When was the Form 4 for THAR insider trading filed relative to the transaction date?
AI-generated analysis. How Rhea-AI works. Not financial advice.